315 related articles for article (PubMed ID: 7979856)
1. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
[TBL] [Abstract][Full Text] [Related]
2. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.
Madhi SA; Petersen K; Madhi A; Khoosal M; Klugman KP
Clin Infect Dis; 2000 Jul; 31(1):170-6. PubMed ID: 10913417
[TBL] [Abstract][Full Text] [Related]
3. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
Shorr AF; Zilberberg MD; Micek ST; Kollef MH
Arch Intern Med; 2008 Nov; 168(20):2205-10. PubMed ID: 19001196
[TBL] [Abstract][Full Text] [Related]
4. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia.
Belliveau P; Hickingbotham N; Maderazo EG; Mazens-Sullivan M; Robinson A
Pharmacotherapy; 1993; 13(4):396-401. PubMed ID: 8361868
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.
Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A
Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Tantiwong P
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia in children at a regional hospital in Trinidad.
Orrett FA; Changoor E
Int J Infect Dis; 2007 Mar; 11(2):145-51. PubMed ID: 16787754
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
[TBL] [Abstract][Full Text] [Related]
10. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap?
Wiener-Well Y; Raveh D; Schlesinger Y; Yinnon AM; Rudensky B
Chemotherapy; 2009; 55(2):97-104. PubMed ID: 19145079
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
[TBL] [Abstract][Full Text] [Related]
12. Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.
Gowardman J; Trent L
N Z Med J; 2000 May; 113(1109):161-4. PubMed ID: 10894342
[TBL] [Abstract][Full Text] [Related]
13. Bacterial pneumonia.
Schneider RF
Semin Respir Infect; 1999 Dec; 14(4):327-32. PubMed ID: 10638512
[TBL] [Abstract][Full Text] [Related]
14. Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.
Iregui MG; Kollef MH
Semin Respir Crit Care Med; 2001 Jun; 22(3):317-26. PubMed ID: 16088683
[TBL] [Abstract][Full Text] [Related]
15. Severe community-acquired pneumonia: an Australian perspective.
Wilson PA; Ferguson J
Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia in adults: initial antibiotic therapy.
King DE; Pippin HJ
Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
